SPPI Investor Alert: Kaplan Fox examines potential
NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in securities of Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”) (NASDAQ: SPPI). If you have purchased Spectrum securities and would like to discuss our investigation, please contact us via email [email protected] or by calling […]
FILING DEADLINE – Kuznicki Law PLLC announces class action lawsuit
CEDARHURST, NY, Nov. 09, 2022 (GLOBE NEWSWIRE) — The securities litigation practice of Kuznicki Law PLLC is issuing this warning to shareholders of Centessa Pharmaceuticals plc (NasdaqGS: CNTA) if they purchased the company’s securities between May and otherwise acquired June 28, 2021 and June 1, 2022 inclusive (the “Collection Period”) and/or the Company’s American Depositary […]
Lifshitz Law PLLC Announces Investigations by RBA, AKUS,
NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) — Ritchie Bros. Auctioneers Incorporated (NYSE: RBA) Lifshitz Law PLLC announces an investigation into a possible breach of fiduciary duties in connection with the sale of IAA, Inc. to RBA for $10.00 per share in cash and 0.5804 RBA common shares for each IAA common share. If you […]
Gainey McKenna & Egleston announces a class action lawsuit
NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announce that it has filed a securities class action in the United States District Court for the Northern District of California on behalf of all individuals or entities that purchased Eiger became BioPharmaceuticals (“Eiger” or “Company”) (NYSE: EIGR) between March 10, 2021 and […]
Major Depressive Disorder Pipeline Analysis: 75+ companies included
DelveInsights, “Insight into the major depressive disorder pipeline2022″, The report provides comprehensive insights into Over 75 companies and over 75 drugs in the pipeline in the pipeline landscape for Major Depressive Disorder. It covers the pipeline drug profiles, including both clinical and non-clinical stage products. It also includes therapeutic evaluation by product type, stage, route […]
Ulcerative Colitis Pipeline Analysis: More than 110 companies are working
DelveInsights, “Insight into the ulcerative colitis pipeline, 2022,” the report provides in-depth insights into 110+ companies and 110+ pipeline drugs in the Ulcerative Colitis (UC) pipeline landscape. It covers the pipeline drug profiles, including both clinical and non-clinical stage products. It also includes therapeutic evaluation by product type, stage, route of administration and molecule type. […]
Obesity Pipeline Analysis: Over 120 companies are working on improvements
DelveInsights, “Insight into the obesity pipeline, 2022,” the report provides deep insights into over 120 companies and over 120 pipeline drugs in the obesity pipeline landscape. It covers the pipeline drug profiles, including both clinical and non-clinical stage products. It also includes therapeutic evaluation by product type, stage, route of administration and molecule type. It […]
Rheumatoid Arthritis Pipeline Analysis: 120+ companies included
DelveInsights, “Insight into the Rheumatoid Arthritis pipeline, 2022,” the report provides in-depth insights into 120+ companies and 120+ pipeline drugs in the Rheumatoid Arthritis (RA) pipeline landscape. It covers the pipeline drug profiles, including both clinical and non-clinical stage products. It also includes therapeutic evaluation by product type, stage, route of administration and molecule type. […]
The law firm of Pomerantz announces the filing of a class action lawsuit
NEW YORK, Nov. 08, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) and certain officers. The class action, filed in the United States District Court for the Northern District of California and filed at 22-cv-06985, is brought on behalf of a class […]
The Pomerantz law firm is investigating claims
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of TFF Pharmaceuticals, Inc. (“TFF” or the “Company”) (NASDAQ: TFFP). Those investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, extension 7980. The investigation concerns whether TFF and certain of its officers and/or directors have […]
Bragar Eagle & Squire, PC examines melon,
NEW YORK, Nov. 06, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is investigating potential claims against Cantaloupe, Inc. (NASDAQ: CTLP, OTCMKTS: CTLPP), EyePoint Pharmaceuticals , Inc (NASDAQ: EYPT), Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) and F45 Training Holdings, Inc. (NYSE: FXLV). Our investigations address whether these companies […]
Bragar Eagle & Squire, PC reminds investors of this class
NEW YORK, Nov. 06, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is reminding investors that class action lawsuits may be filed on behalf of shareholders of Olo, Inc. (NYSE: OLO ), Centessa Pharmaceuticals Plc (NASDAQ: CNTA), PayPal Holdings, Inc. (NASDAQ: PYPL) and Opendoor Technologies, Inc. (NASDAQ: […]